Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Alastair Smith, Avacta Group CEO gives an Operational Update


Shire Share Price (SHP)



Share Price Information for Shire (SHP)


Share Price: 4,569.00Bid: 4,561.00Ask: 4,562.50Change: 0.00 (0.00%)No Movement on Shire
Spread: 1.50Spread as %: 0.03%Open: 4,499.50High: 4,571.00Low: 4,499.50Yesterday’s Close: 4,569.00

Shire Plc Ord 5P

Shire is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 Low Yield
Shire is part of the Medicine and Biotech Research sector

Founded in 1986. Products available in more than 100 countries. Operate in North America, Latin America, Europe and Asia. Group headquarters Dublin, Ireland. Over 23,500 employees, 37 clinical programs in development. Revenue 11.4 billion USD ( 2016 )





Share Price SpacerPrice
4569.00
Share Price SpacerBid
4561.00
Share Price SpacerAsk
4562.50
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
3,806,735
Share Price SpacerOpen
4,499.50
Share Price SpacerHigh
4,571.00
Share Price SpacerLow
4,499.50
Share Price SpacerClose
4,569.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX JE 784.27m £35,833.44m 500

52 Week High 4,576.00 52 Week High Date 28-AUG-2018
52 Week Low 2,940.50 52 Week Low Date 21-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
9,978 1,348,197 2,158,531 13.037 350.45 24.49 0.54


London South East Users info for Shire




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Sep-18
18:45:02
4,541.979
5,746
Sell* 
4,561.00
4,562.50
260.98k
Trade Type:
Ordinary

21-Sep-18
18:45:02
4,541.979
337
Sell* 
4,561.00
4,562.50
15.31k
Trade Type:
Ordinary

21-Sep-18
18:06:52
4,569.457
73,616
Buy* 
4,561.00
4,562.50
3.364M
Trade Type:
Ordinary




View more Shire trades >>

Directors Deals for Shire (SHP)
Trade DateActionNotifierPriceCurrencyAmountHolding
31-Oct-17Exercise of option
Trade Notifier Information for Shire Plc
Flemming Ornskov held the position of CEO at Shire Plc at the time of this trade.
 Flemming Ornskov
41.3USD300189588
31-Oct-17Exercise of option
Trade Notifier Information for Shire Plc
Jeff Poulton held the position of CFO at Shire Plc at the time of this trade.
 Jeff Poulton
41.3USD3006044
29-Sep-17Buy
Trade Notifier Information for Shire Plc
Susan Kilsby held the position of Chairman at Shire Plc at the time of this trade.
 Susan Kilsby
50.86USD53481495
View more Shire directors dealings >>


luddite
Posts: 312
Opinion:Buy
Price:4,333.50
Takeover
6 Sep '18
Offer value approx £49.61 today , approx 15% upside (if it gets all clearances, Takeda price holds, and $ and yen stay put against £) whats the odds on it all happening ? I remember SabMiller and a few other big ones at this stage in the takeover game and many people doubting they would get through the hoops but more often than not they do. My main concern is the possibility of a market correction.
tigertrader17
Posts: 105
Opinion:No Opinion
Price:4,518.00
SHIRE ANNOUNCES CASH TENDER OFFERS
24 Aug '18
Dublin, Ireland – August 24, 2018 – Shire plc (LSE: SHP and NASDAQ: SHPG) (“Shire”), Baxalta Incorporated, a Delaware corporation and wholly-owned subsidiary of Shire (“Baxalta”), and Shire Acquisitions Investments Ireland DAC, an Irish designated activity company and wholly-owned subsidiary of Shire (“SAIIDAC” and, together with Baxalta, the “Offerors”), announced today that the Offerors have commenced cash tender offers (collectively, the “Tender Offers,” and each offer to purchase a series of notes individually, a “Tender Offer”) to purchase up to $2,250,000,000 aggregate principal amount (the "Aggregate Maximum Purchase Amount") of Baxalta’s outstanding 2.875% Senior Notes due 2020, 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025 and 5.250% Senior Notes due 2045 and SAIIDAC’s outstanding 3.200% Senior Notes due 2026 (collectively, the “Notes”). Baxalta is the Offeror for the notes issued by it, and SAIIDAC is the Offeror for the notes issued by it.

The Tender Offers are not conditioned upon a minimum amount of Notes of any series, or a minimum amount of Notes of all series, being tendered. However, the Tender Offers are subject to, and conditioned upon, the satisfaction or waiver of certain conditions described in the Offer to Purchase, including the closing of, and receipt by Shire of the cash proceeds from, the sale of Shire’s Oncology business.
mrcautious
Posts: 2,875
Opinion:No Opinion
Price:4,528.00
Looking Promising
24 Aug '18
today. A jump based on new drug approval, there is good value here
casapinos
Posts: 544
Opinion:No Opinion
Price:4,409.00
goodbye!
1 Aug '18
Sold today , I said back in may that I would hang around until £45 but happy top take a profit and move on . The remaining £5 will take around 6 months to appear, so i'm happy to leave it for someone else.
ScaleyBack
Posts: 24
Opinion:Hold
Price:4,350.00
RE: Watch the share price fly!
25 Jul '18
Unlike many here who claim to have bought in at rock bottom prices, I bought in at an average of 4,892 so I am stuck until the end of the year when I expect them to return to this figure. Then it's sell.

Whatever made me choose Pharma stock? Oh yes, it seemed a good idea at the time.
View more share chat for Shire (SHP) >>




Shire Plc Ord 5P home pageWebsite: Shire Plc Ord 5P
Website Description: Founded in 1986. Products available in more than 100 countries. Operate in North America, Latin America, Europe and Asia. Group headquarters Dublin, Ireland. Over 23,500 employees, 37 clinical programs in development. Revenue 11.4 billion USD ( 2016 )



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.